Issue 7, 2015

Self-assembled micelles of amphiphilic PEGylated rapamycin for loading paclitaxel and resisting multidrug resistant cancer cells

Abstract

Self-assembled micelles of amphiphilic PEG–rapamycin conjugates loaded with paclitaxel have been developed for co-delivery and simultaneous intracellular release of paclitaxel and rapamycin, bypassing the cancer cell drug resistant mechanism and maximising the synergy of dual-drug combinational therapy. This novel nanomedicine offers 20-fold improved potency over free paclitaxel against a model multidrug resistant human breast cancer cell.

Graphical abstract: Self-assembled micelles of amphiphilic PEGylated rapamycin for loading paclitaxel and resisting multidrug resistant cancer cells

Supplementary files

Article information

Article type
Communication
Submitted
01 oct. 2014
Accepted
19 ene. 2015
First published
26 ene. 2015
This article is Open Access
Creative Commons BY license

J. Mater. Chem. B, 2015,3, 1204-1207

Author version available

Self-assembled micelles of amphiphilic PEGylated rapamycin for loading paclitaxel and resisting multidrug resistant cancer cells

W. Tian, J. Liu, Y. Guo, Y. Shen, D. Zhou and S. Guo, J. Mater. Chem. B, 2015, 3, 1204 DOI: 10.1039/C4TB01633E

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements